Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures

Grant

Date/time Interval

  • November 1, 2015 - October 31, 2020
  • Awarded By

    Total Award Amount

  • 0.00
  • Direct Costs

  • 0.00
  • Sponsor Award Id

  • Contributor

  • Agarwal, Garima   Investigator  
  • Carroll M.D., William   Principal Investigator  
  • Greene, Benjamin   Investigator  
  • Morlandt D.D.S., M.D., Anthony   Investigator  
  • Nabell M.D., Lisle   Investigator  
  • Stevens, Todd   Investigator  
  • Warram, Jason   Investigator  
  • Withrow, Kirk   Investigator